AU2003209049A8 - Methods of treating and diagnosing arthritis - Google Patents

Methods of treating and diagnosing arthritis

Info

Publication number
AU2003209049A8
AU2003209049A8 AU2003209049A AU2003209049A AU2003209049A8 AU 2003209049 A8 AU2003209049 A8 AU 2003209049A8 AU 2003209049 A AU2003209049 A AU 2003209049A AU 2003209049 A AU2003209049 A AU 2003209049A AU 2003209049 A8 AU2003209049 A8 AU 2003209049A8
Authority
AU
Australia
Prior art keywords
treating
methods
diagnosing arthritis
diagnosing
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209049A
Other versions
AU2003209049A1 (en
Inventor
Christophe O Benoist
Diane J Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU2003209049A1 publication Critical patent/AU2003209049A1/en
Publication of AU2003209049A8 publication Critical patent/AU2003209049A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
AU2003209049A 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis Abandoned AU2003209049A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35604102P 2002-02-11 2002-02-11
US60/356,041 2002-02-11
US35777502P 2002-02-19 2002-02-19
US60/357,775 2002-02-19
PCT/US2003/003708 WO2003068150A2 (en) 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis

Publications (2)

Publication Number Publication Date
AU2003209049A1 AU2003209049A1 (en) 2003-09-04
AU2003209049A8 true AU2003209049A8 (en) 2003-09-04

Family

ID=27737514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209049A Abandoned AU2003209049A1 (en) 2002-02-11 2003-02-06 Methods of treating and diagnosing arthritis

Country Status (2)

Country Link
AU (1) AU2003209049A1 (en)
WO (1) WO2003068150A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095154A2 (en) 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
HUE026001T2 (en) * 2007-02-05 2016-04-28 Apellis Pharmaceuticals Inc Compstatin analogues for use in the treatment of inflammatory conditions of the respiratory system
US9248162B2 (en) 2013-03-14 2016-02-02 Baxalta Incorporated Factor H for treatment of rheumatoid arthritis
JP7156827B2 (en) * 2018-06-08 2022-10-19 デンカ株式会社 Reagent for measuring complement titer and method for stabilizing measured value of complement titer using the same
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894002A4 (en) * 1996-03-13 2001-11-14 Univ Pennsylvania Novel peptides which inhibit complement activation
US6956107B2 (en) * 1998-02-20 2005-10-18 Tanox, Inc. Inhibitors of complement activation
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis

Also Published As

Publication number Publication date
WO2003068150A2 (en) 2003-08-21
AU2003209049A1 (en) 2003-09-04
WO2003068150A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
EP1565644A4 (en) Well treating process and system
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
EP1565187A4 (en) Methods of treating cancer and related methods
AU2003259925A8 (en) Well treatment apparatus and method
HK1156521A1 (en) Methods of treating pre-eclampsia
EP1398930A4 (en) Radio-frequency-signal-receiver and method of manufacturing the same
EP1505961A4 (en) Methods of treating allergic reactions
ZA200405329B (en) Method and device of the production of brushes
AU2003277259A8 (en) Immunoassay and method of use
EP1476150A4 (en) Carboxyfullerenes and methods of use thereof
EP1567198A4 (en) Materials and methods for treating ocular-related disorders
HK1063816A1 (en) Fixation nterlining and method for its production
EP1484622A4 (en) Prism and method of producing the same
EP1491091A4 (en) Insect-proofing means and method of insect-proofing
AU2003209049A8 (en) Methods of treating and diagnosing arthritis
EP1545287A4 (en) Vasoregulating compounds and methods of their use
AU2003276398A8 (en) Shearwall structure and method of making the same
AU2003270622A8 (en) Methods of diagnosing and treating hyperproliferative disorders
GB0221712D0 (en) Methods of treatment
EP1483407A4 (en) Methods of therapy and diagnosis
AU2003209534A8 (en) The method of treating tuberculosis
EP1567863A4 (en) Methods of therapy and diagnosis
GB0206698D0 (en) Screening method and method of treatment
GB0209987D0 (en) Screening method and method of treatment
GB0202872D0 (en) Screening method and method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase